Lomudal Augndropar, lausn 20 mg/ml Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

lomudal augndropar, lausn 20 mg/ml

stada arzneimittel ag - sodium cromoglicate - augndropar, lausn - 20 mg/ml

Ibandronic acid WH Stungulyf, lausn 3 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

ibandronic acid wh stungulyf, lausn 3 mg

williams & halls ehf - acidum ibandronicum mónónatríum - stungulyf, lausn - 3 mg

Solifenacin Alvogen 10 mg Filmuhúðuð tafla (Solifenacin Portfarma) Filmuhúðuð tafla 10 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

solifenacin alvogen 10 mg filmuhúðuð tafla (solifenacin portfarma) filmuhúðuð tafla 10 mg

alvogen ehf. - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg

Lacosamide Adroiq Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lacosamíð - flogaveiki - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.